According to the 15-minute chart on OneMedNet, a MACD Death Cross and narrowing Bollinger Bands have been observed at 11:00 on October 17, 2025. This suggests that the stock price has the potential to continue declining, with a decreasing magnitude of price fluctuations.
Palantir Technologies Inc. (NASDAQ:PLTR), a leading provider of data integration and analytics platforms, has entered into a strategic partnership with OneMedNet to enhance its offerings in healthcare AI and real-world data analytics, according to
. The collaboration, announced on October 6, 2025, aims to integrate Palantir's Artificial Intelligence Platform (AIP) into OneMedNet's infrastructure, with the goal of accelerating insights, cohort building, and analytic delivery.
Palantir's AIP is designed to connect generative AI and operations in regulated or high-stakes environments. This platform is part of Palantir's suite of products, which includes Foundry, Gotham, and Apollo, designed for data integration, modeling, and decision support across government and commercial domains; the Yahoo Finance article discusses these capabilities in the context of the partnership. The partnership between Palantir and OneMedNet signifies a significant step in leveraging AI to improve healthcare outcomes and operational efficiency.
Investors should note that while Palantir is a fast-growing AI stock with promising potential, it may not be the best choice for those seeking extreme undervalued AI stocks with significant upside potential and lower downside risk, as the Yahoo Finance article explains. For those looking for such investments, a recent report highlights other AI stocks that might offer greater upside and less downside risk.
According to the 15-minute chart on OneMedNet, a MACD Death Cross and narrowing Bollinger Bands were observed at 11:00 on October 17, 2025. This technical analysis suggests a potential continuation of the stock price decline, with decreasing price fluctuations .
Comments
No comments yet